Inventor · disambiguated record
Rachel Y. Labell
Also filed as: LABELL RACHEL · LABELL RACHEL Y · LABELL RACHEL YVONNE
7 granted patents·18 pending applications·134 citations·filing 2003–2024
86Inventor score
Top patents by PatentIndex Score
25 records- 0197US9149464B2Bendamustine derivatives and methods of using sameIGNYTA INC·Filed 2015·Granted Oct 6, 2015·40 cites·19 claims
- 0297US9150517B2Bendamustine derivatives and methods of using sameIGNYTA INC·Filed 2015·Granted Oct 6, 2015·40 cites·2 claims
- 0397US8344006B2Liquid formulations of bendamustineCEPHALON INC·Filed 2012·Granted Jan 1, 2013·51 cites·10 claims
- 0487US9452988B2Bendamustine derivatives and methods of using sameIGNYTA INC·Filed 2013·Granted Sep 27, 2016·3 cites·25 claims
- 0574US2021113530A1Liquid formulations of bendamustineCEPHALON INC·Filed 2020·Application pending·0 cites
- 0672US2021008035A1Liquid formulations of bendamustineCEPHALON INC·Filed 2020·Application pending·0 cites
- 0772US2014206733A1Liquid Formulations Of BendamustineCEPHALON INC·Filed 2014·Application pending·0 cites
- 0871US2014128443A1Liquid Formulations Of BendamustineCEPHALON INC·Filed 2014·Application pending·0 cites
- 0970US2018147186A1Bendamustine derivatives and methods of using sameIGNYTA INC·Filed 2018·Application pending·0 cites
- 1069US2018125824A1Liquid formulations of bendamustineDRAGER ANTHONY S·Filed 2017·Application pending·0 cites
- 1168US2025049767A1Formulations, methods, kits, and dosage formsSUN ZHAOLI·Filed 2024·Application pending·0 cites
- 1267US2013041004A1Liquid Formulations Of BendamustineDRAGER ANTHONY S·Filed 2012·Application pending·0 cites
- 1366US12115149B2Formulations, methods, kits, and dosage formsMEDREGEN LLC·Filed 2021·Granted Oct 15, 2024·0 cites·9 claims
- 1466US9913827B2Bendamustine derivatives and methods of using sameIGNYTA INC·Filed 2017·Granted Mar 13, 2018·0 cites·20 claims
- 1565US2015335750A1Liquid Formulations of BendamustineCEPHALON INC·Filed 2015·Application pending·0 cites
- 1664US2011190363A1Liquid formulations of bendamustineCEPHALON INC·Filed 2011·Application pending·0 cites
- 1764US2016016912A1Bendamustine derivatives and methods of using sameIGNYTA INC·Filed 2015·Application pending·0 cites
- 1864US2014080881A1Liquid Formulations of BendamustineCEPHALON INC·Filed 2013·Application pending·0 cites
- 1963US9630926B2Bendamustine derivatives and methods of using sameIGNYTA INC·Filed 2016·Granted Apr 25, 2017·0 cites·18 claims
- 2050US2008200862A1Method To Administer Stem Cells In Combination With One Or More Acoustically Active Materials And Ultrasound EnergyIMARX THERAPEUTICS INC·Filed 2005·Application pending·0 cites
- 2149US2013144068A1Methods for the Sterilization of BendamustineCEPHALON INC·Filed 2013·Application pending·0 cites
- 2245US2004009229A1Stabilized nanoparticle formulations of camptotheca derivativesFiled 2003·Application pending·0 cites
- 2345US2012157505A1Oral formulations of bendamustineLABELL RACHEL Y·Filed 2011·Application pending·0 cites
- 2445US2004247624A1Methods of making pharmaceutical formulations for the delivery of drugs having low aqueous solubilityFiled 2003·Application pending·0 cites
- 2539US2009112150A1Cavitation enhanced treatment through local deliveryIMARX THERAPEUTICS INC·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Rachel Y. Labell files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →